BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $590,000 | -79.8% | 3,899 | -80.5% | 0.00% | -66.7% |
| Q2 2022 | $2,914,000 | -41.8% | 20,004 | -72.7% | 0.00% | -25.0% |
| Q1 2021 | $5,006,000 | -69.7% | 73,232 | -62.0% | 0.00% | -69.2% |
| Q4 2020 | $16,504,000 | -54.9% | 192,562 | -65.8% | 0.01% | -51.9% |
| Q3 2020 | $36,603,000 | +10.1% | 563,040 | +23.9% | 0.03% | -30.8% |
| Q2 2020 | $33,231,000 | +781.2% | 454,509 | +310.2% | 0.04% | +680.0% |
| Q1 2020 | $3,771,000 | +305.9% | 110,812 | +422.5% | 0.01% | +400.0% |
| Q2 2019 | $929,000 | -87.3% | 21,209 | -85.1% | 0.00% | -87.5% |
| Q1 2019 | $7,327,000 | +841.8% | 142,349 | +577.2% | 0.01% | +700.0% |
| Q4 2018 | $778,000 | -35.3% | 21,019 | -54.9% | 0.00% | 0.0% |
| Q1 2018 | $1,202,000 | +2695.3% | 46,653 | +2823.1% | 0.00% | – |
| Q4 2017 | $43,000 | – | 1,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |